Request to Join
has invited you to join this group
Dr. Richard D. Goldstein is Assistant Professor of Pediatrics at Boston Children’s Hospital and Harvard Medical School. He is a pediatric palliative care physician with a background in general pediatrics and behavioral-developmental pediatrics. In 2012, Dr. Goldstein co-founded Robert’s Program in Sudden Unexpected Death in Pediatrics with Dr. Hannah C. Kinney, a translational clinical program approaching sudden unexpected death in children as an undiagnosed disease, bringing the most current diagnostic approaches and insights to the care and counseling of affected families. The program also conducts research and promotes advocacy for sudden death in pediatrics. Dr. Goldstein has published extensively in original reports and book chapters on palliative care, as well as childhood mortality and SIDS. He recently published a large epidemiological analysis of SIDS rates in the United States from 1983 to 2012 illustrating the influence of inherent biological aspects in SIDS mortality. He is involved in the design and the analysis of basic research on sudden unexpected death in pediatrics, and serves to phenotype cases and controls comprehensively in studies of underlying brain and genetic vulnerabilities in SIDS and SUDC. Dr. Goldstein was an organizer and leader for the NICHD Workshop on Sudden Unexpected Death in Fetal Life through Early Childhood in March 2015.
His ongoing research interests also include the characterization of grief in a parent after the loss of a child, cultural and socioeconomic influences upon parental grief, and behavioral adaptation of children and families to extraordinary circumstances, e.g., war, sudden unexpected death of a seemingly healthy child, raising a family member with Down Syndrome. He is a grief investigator in the Safe Passage Study, an international, prospective study of the relationship of adverse prenatal exposures to stillbirth and SIDS in 12,000 maternal-infant dyads in high risk, socioeconomically disadvantaged populations. He served on the Steering Committee of the National Quality Forum’s National Voluntary Consensus Standards for Palliative Care and End-of-Life Care Project. He also serves as the Bereavement Medical Director for First Candle, a national organization supporting parents whose infants died from SIDS.
Dr. Martin Arrigan is a diagnostic radiologist originally from Dublin, Ireland. He is currently finishing fellowship training in University of Toronto, Canada prior to commencing a radiologist post at the University of British Columbia in January.
He graduated from medical school in Trinity College Dublin, Ireland in 2008 with first class honours in medicine and won several prizes and research bursaries. After 2 years in internal medicine he decided to persue a career in diagnostic radiology with the Royal College of Surgeons in Ireland at St James's Hospital Dublin.
He has a longstanding and personal interest in Sudden Athlete Cardiac Death and is the first author of the paper "Imaging Spectrum of Sudden Athlete Cardiac Death" published in Clinical Radiology in 2011. (http://www.ncbi.nlm.nih.gov/pubmed/21295200). He is certified in Cardiac CT by the advanced imaging program at University of Toronto. In addition to sudden athlete death his interests include medical physics and education.
Along with his interest in cardiac imaging he is fellowship trained in both Diagnostic Neuroradiology at the University of British Columbia and Musculoskeletal radiology at the University of Toronto. Prior to his career in medicine Dr Arrigan trained as a pharmacist at Trinity College Dublin, graduating in 2001.
Jonathan R. Kaltman, M.D., is chief of the Heart Development and Structural Diseases Branch in the Division of Cardiovascular Sciences at the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH). Dr. Kaltman joined the NHLBI in 2008. In this role, Dr. Kaltman is responsible for developing new research initiatives and managing basic and clinical research grants in the areas of pediatric cardiology, congenital cardiac genomics, sudden cardiac death, muscular dystrophy, and other pediatric cardiology-related disease states. Dr. Kaltman provides leadership for the Pediatric Cardiac Genomics Consortium, a multi-center translational research group investigating the association of genetic variation with congenital heart disease diagnosis and outcome. He also helps oversee the Pediatric Heart Network, a multi-center clinical research network conducting studies in children with congenital heart disease, and the Sudden Death in the Young Initiative.
Prior to joining the NHLBI, Dr. Kaltman served as an Assistant Professor of Pediatrics at the Children’s Hospital of Philadelphia. He then joined the Children’s National Medical Center in the District of Columbia where he still holds a part-time position. He is an Adjunct Associate Professor of Pediatrics at George Washington University and the Children’s National Medical Center. His responsibilities include: outpatient pediatric cardiology/electrophysiology care, participation in catheter ablation procedures, electrophysiology consults, and education of residents and fellows.
Dr. Kaltman received his Bachelor of Science in molecular biophysics and biochemistry from Yale University, New Haven, Conn., and earned his Doctor of Medicine from Emory University School of Medicine, Atlanta. Dr. Kaltman is a member of the Heart Rhythm Society and the American Heart Association.
Areas of expertise: pediatric cardiology and electrophysiology, congenital cardiac genomics, and sudden cardiac death
Associate Professor David Prior is Deputy Director of Cardiology, Director of Non-invasive Cardiac Imaging and Head of the Heart Failure Clinic at St Vincent’s Hospital, Melbourne. After training in cardiology at the Alfred Hospital, he completed a PhD in heart failure at the Baker Heart Research Institute and subsequently a cardiac imaging fellowship at the Cleveland Clinic Foundation, Ohio. He has worked at St Vincent’s Hospital since 2000 and also holds a position as Associate Professor at the University of Melbourne. Major clinical and research interests are in heart failure management, cardiac imaging, sports & exercise cardiology and pulmonary hypertension. He is particularly interested in early diagnosis of disease with the aim of early treatment to improve long term outcomes.
Prof. Jean-Claude Chatard MD, PhD is certified in Sports Cardiology, Sports Medicine and Exercise Physiology at the University Hospital and Faculty of Medicine of Saint-Etienne, France. He has a 35-year experience as a medical doctor for elite athletes worldwide, France, Qatar, Australia, USA. From 2011 to 2016, his research focus on cardiac screening for young and master athletes, resting and stress ECG, Holter blood pressure and rhythm troubles, echocardiography, scintigraphy, coro scan, coronarography and cardiac MRI. He is consultant for the French 1stLeague Professional Football Team of Saint-Etienne. From 2007 to 2011, he worked as senior consultant in Aspetar-Aspire Hospital, Doha – Qatar and created a cardiac screening department for professional and elite athletes. He was responsible for the Sports Cardiology Project providing direct patient care and decision for complementary exploration. From 2004 to 2007, he was Chief Medical Officer in Saint-Etienne University and Hospital - France leading a 10 m€ project dedicated to evidence-based Sports Medicine Services and Enginery Research. Dr Chatard has authored or co-authored 124 peer-reviewed publications and 33 book chapters. He has provided over 230 invited lectures for national and international professional groups. He is acting as a reviewer for 24 scientific journals including 16 Pub Med indexed journals. He has a >50-year of swimming and triathlon practice with regular competitions, being a former World Champion and multiple European Record Holder in Master Swimming.
Dr. Roberts a Professor in the Department of Family Medicine and Community Health at the University of Minnesota Medical School. His special medical interests are in sports medicine and he has a sub-specialty certificate in Sports Medicine, is a Fellow, Past President, and Past Foundation President of the American College of Sports Medicine; a charter member of the American Medical Society of Sports Medicine; a founding member and past President of the International Institute of Race Medicine (formerly the American Road Race Medical Society); Editor in Chief for Current Sports Medicine Reports; an Editorial Board Member of Medicine and Science in Sports and Exercise, British Journal of Sports Medicine, and Clinical Journal of Sport Medicine; the Medical Director for Twin Cities in Motion and the Medtronic Twin Cities Marathon; the Chair of the Sports Medicine Advisory Committee for the Minnesota State High School League; and a member of the USA Soccer Cup Tournament Sports Medicine Advisory Committee. His research is in ice hockey and marathon related illness and injury. Dr Roberts has authored or co-authored 131 peer-reviewed publications and 32 book chapters. He has provided over 300 invited lectures for national and international professional groups.
Dr Mark McGuire is a cardiac electrophysiologist. He is senior staff cardiologist at the Royal Prince Alfred Hospital and Prince of Wales Hospitals in Sydney Australia, Chairman of Cardiovascular Medicine at the Mater Hospital in Sydney and Clinical Professor of Medicine at the University of Sydney. His research interests include the atrioventricular node, atrioventricular nodal re-entrant tachycardia, sudden death in the young, atrial fibrillation and, in particular, the biophysics of cryoballoon ablation of atrial fibrillation. He has delivered numerous papers to national and international scientific meetings, is a past chairman of the EP and Pacing Working Group of The Cardiac Society of Australia and New Zealand and has served on the Editorial Board of the Journal of Cardiovascular Electrophysiology and Heart Rhythm.
Sanjay Sharma is Professor of cardiology and head of research for the clinical and academic group at St George’s University of London and St George’s NHS Foundation trust. His interests, sudden cardiac death in the young, heart muscle disease and cardiovascular adaptation in athletes for which he has an international reputation and has over 185 PubMed citations (mainly senior author) citations. He regularly lectures and major scientific meetings including the AHA, ACC and ESC.
Dr Sharma leads a large tertiary inherited cardiac diseases program serving South East England to manage patients with cardiomyopathy and ion channel diseases.
He is director for the largest sports cardiology unit in the UK which is responsible for a large number of athletes with potentially serious cardiac diseases from the British premier soccer and rugby league, Lawn Tennis association and the English institute of sport. He is the cardiology advisor for the British rowing team, Sky cycling squad and is the chairman for the expert cardiac committee for the football association. He is medical director of the London marathon and was the lead cardiologist for the 2012 London Olympics. Dr Sharma is chairman of the ESC sports cardiology nucleus and congress programme committee member of the European Society of Cardiology in Preventive Cardiology. Professor Sharma has dedicated a large proportion of his research in understanding the athlete’s EKG
Working with the charitable organisation, Cardiac Risk in the Young, Dr Sharma leads the largest cardiac screening programme in the UK for individuals aged 14-35 years old. The charity screens over 20,000 individuals each year from which several data sets have been developed to provide an estimate of the number of young individuals harbouring potentially serious cardiac diseases. He is involved in a large prospective study to assess the efficacy of the ECG in preventing sudden cardiac death in the young.
Dr Sharma enjoys teaching and is the senior tutor for the MRCP part 2 written programme for the Royal College of Physicians. He has written several education book in clinical medicine.
Gaetano Thiene M.D. is Professor of Pathology and Consultant of Cardiovascular Pathology, Department of Cardiac, Thoracic and Vascular Sciences at the University of Padua Medical School, Padua, Italy.
His research interests have been across the broad fields of Cardiovascular Medicine and Pathology, particularly directed to clinicopathologic studies and clinical translation of basic research.
He first reported Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) as a major cause of sudden death in the young and in athletes (NEJM 1988) and has contributed to the elucidation of the genetic basis for ARVC (Circulation 2006). He is a principal architect of the Italian program in which all young individuals who participate in sports activities are screened for potential cardiovascular problems and in which all sudden unexpected deaths in the young are formally investigated by expert cardiovascular pathologists. This is the most successful such screening program in the world and it has led to major advances in understanding the causes of sudden death in the young. It resulted in a sharp decline (by 90%) of sudden death in the athletes of the Veneto Region, Italy, thanks to identification and disqualification of young people affected by cardiomyopathies. Dr. Thiene has been and continues to be a true visionary in this field.
Dr. Thiene is the leader of the group in Padua which has worked at the interface between pathology and genetics in the cardiomyopathies and has identified several disease-causing mutations, correlating them with the clinical and pathological features of the disease. He has given important contributions to defining clinicopathologic correlations in heart valve disease and in the pathology of tissue valve substitutes, including the initial observation that calcification in human bioprostheses was initiated in cells. Dr. Thiene has made several contributions to congenital heart disease, molecular genetics and pathology of myocarditis, coronary artery disease, arrhythmias and conduction system disease, cardiac tumors, endomyocardial biopsy and cardiac transplantation.
He has published 1015 reports of original investigations and reviews in Index leading journals of pathology and cardiovascular medicine, and additionally is co-author and/or co-editor of 21 monographs. His papers collected an overall Impact Factor of 3860,789; Times cited: 31450; Hirch index 81 (Scopus since 1995).
Dr. Thiene is Associate Editor of Cardiovascular Pathology and serves in the Editorial Board and/or acts as reviewer of many prestigious journals in cardiology, medicine and pathology.
Moreover, Dr. Thiene has been a tireless champion of and participant in the Society for Cardiovascular Pathology (SCVP), of Cardiovascular Pathology as a subspecialty as well as of international cooperation. He has been one of the founders, a major driver of the Association for European CardioVascular Pathology (AECVP) and has motivated young people in Europe to enter the field of Cardiovascular Pathology, training several as a direct mentor. More generally he has led the definition of educational and training requirements for Cardiovascular Pathology.
Domenico Corrado, MD, PhD, FESCFull-Professor of Cardiovascular MedicineDirector of the Inherited Arrhythmogenic Cardiomyopathy Unit Department of Cardiac, Thoracic and Vascular SciencesUniversity of Padua Medical School, ITALY
Doctor Ackerman is the Windland Smith Rice Cardiovascular Genomics Research Professor and Professor of Medicine, Pediatrics, and Pharmacology at the Mayo Clinic in Rochester, Minnesota. As Director of Mayo’s Long QT Syndrome/Genetic Heart Rhythm Clinic and the Windland Smith Rice Sudden Death Genomics Laboratory, Dr. Ackerman strives to fulfill the two-fold objective of medical education and biomedical research as stated by Dr. Charles H. Mayo: “to heal the sick and to advance the science.” He has published over 400 articles and chapters across the continuum of basic, translational, and clinical research focusing on the cardiac channelopathies, hypertrophic cardiomyopathy, and sudden cardiac death in the young. Dr. Ackerman received his MD and PhD from Mayo Medical School and Mayo Graduate School and residency and fellowship training in Pediatric and Pediatric Cardiology in Mayo Clinic’s Graduate School of Medicine. Dr. Ackerman is also the president of the Sudden Arrhythmia Death Syndromes Foundation.
Dr. Bo Gregers Winkel is a cardiologist and researcher in sudden cardiac death in the young at University Hospital Copenhagen, Rigshospitalet.
Dr Behr is Reader in Cardiovascular Medicine and Honorary Consultant Cardiologist specialising in Electrophysiology at St George's University of London and St George's Hospital, London. He studied medical sciences at St John's College, University of Cambridge and completed undergraduate training with distinction in 1993 at Guy's Hospital, London. Dr Behr’s clinical and research interest is in sudden death and its genetic, clinical, epidemiological and pathological investigation. His aim is to develop novel approaches to risk stratification and prevention in conditions that predispose to the risk of sudden death. This includes the long QT and Brugada syndromes, drug-induced arrhythmia and unexplained sudden death in infants (SIDS), children and adults (SADS) as well as sudden death in the general population and acquired disease groups.
Dr Maria Brosnan is a Cardiologist at St Vincent’s Hospital, Melbourne and the Baker IDI Melbourne, Australia. Dr Brosnan is the author of a number of high impact publications on the topic of electrocardiographic (ECG) screening young athletes to detect cardiac conditions associated with sudden cardiac death, having completed a PhD on the topic. Her research, which studied a unique cohort of 2,000 truly elite endurance and non-endurance athletes, has provided some novel insights into how cardiac adaptations to exercise are reflected in the ECG, and addressed some of the important limitations of ECG screening. Dr Brosnan’s clinical interests include the diagnosis and management of inherited cardiac disorders, with a particular focus on the management of athletes with both inherited and acquired cardiac conditions. She provides cardiology support to a number of elite sporting teams and organisations within Australia. Dr Brosnan is currently completing a fellowship in advanced cardiac imaging techniques in echocardiography and cardiac magnetic resonance imaging (CMR). Ongoing research collaborations are focused on the complex interplay between exercise and genetics and both inherited and acquired cardiovascular disease.
Sports Cardiology; Sudden Cardiac Death; Cardiovascular Genetics; Electrocardiography; Cardiac imaging; Echocardiography, Cardiac MRI